SCHEMBL8285686

SCHEMBL8285686

Nc1nc2cc(CO)ccc2n1Cc1ccc(F)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOS1 Q07889 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ HTT P42858 2/20 0.49
▸ POLB P06746 1/20 0.49
▸ TNF P01375 1/20 0.49
▸ CXCL8 P10145 1/20 0.49
▸ NOD2 Q9HC29 1/20 0.49
▸ NOD1 Q9Y239 1/20 0.49
▸ KMT2A Q03164 2/20 0.48
▸ CSF1R P07333 1/20 0.47
▸ NUDT1 P36639 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ RPS6KA5 O75582 1/20 0.44
▸ TBXA2R P21731 4/20 0.44
▸ RAB9A P51151 1/20 0.43
▸ KCNK13 Q9HB14 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285687 0.89 SOS1 (0.49) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL30581414 0.86 POLB (0.49) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL5466787 0.82 AGTR1 (0.56) SOS1ALDH1A1HTTPOLBTNF
Nitrous Acid SCHEMBL25426326 0.81 POLB (0.44) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL8285688 0.80 SOS1 (0.46) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL9630558 0.80 TNF (0.75) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL12658348 0.79 SOS1 (0.56) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL16456515 0.79 ALDH1A1 (0.57) SOS1ALDH1A1HTTPOLBTNF
Hydrochloric Acid SCHEMBL11594488 0.78 TNF (0.73) SOS1ALDH1A1HTTPOLBTNF
SCHEMBL8284617 0.77 RPS6KA5 (0.47) SOS1ALDH1A1HTTPOLBTNF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
EP-1697343-B1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2009-07-01 — — EP disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
WO-2005058869-A1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 SOS1 2168/4885ALDH1A1 1319/4885HTT 2862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback